期刊文献+

头颈部鳞癌人乳头瘤病毒感染与p16和表皮生长因子受体表达及患者预后的关系 被引量:8

Relationship between human papilloma virus infection and expression of p16 and EGFR in head andneck squamous cell carcinoma and their prognostic significance
原文传递
导出
摘要 目的探讨人乳头瘤病毒(HPV)感染与p16、表皮生长因子受体(EGFR)表达和头颈部鳞癌患者预后的关系。方法采用原位杂交技术和免疫组化法检测HPV感染、p16和EGFR的表达情况。采用Kaplan-Meier法计算生存率,采用Cox比例风险模型分析影响患者预后的独立因素。结果本组43例患者中,HPV感染11例,感染率为25.6%,均为汉族。其中HPV16/18感染率为63.6%,HPV31/33感染率为27.3%,HPV16/18和HPV31/33共同感染率为9.1%。p16阳性表达率为53.5%,EGFR阳性表达率为69.8%。HPV阳性患者的民族、吸烟、饮酒情况与HPV阴性组患者比较,差异均有统计学意义(均P〈0.05)。HPV感染与p16和EGFR表达均有关(均P〈0.05)。p16表达与EGFR表达呈负相关(r=-0.447,P=0.003)。HPV阳性组和阴性组患者的3年生存率分别为60.0%和59.7%,差异无统计学意义(P=0.789)。p16阳性组和阴性组患者的3年生存率分别为72.2%和43.9%,差异有统计学意义(P=0.012),EGFR阳性组和阴性组患者的3年生存率分别为48.8%和81.8%,差异有统计学意义(P=0.037)。结论维吾尔族和汉族头颈部鳞癌患者HPV的感染率可能存在差异。HPV感染与p16和EGFR表达有关。p16表达是影响头颈部鳞癌患者预后的独立因素。 Objective To detect the infection of human papillomavirus (HPV) 6/11, 16/18, 31/33 in patients with head and neck squamous cell carcinoma and explore the relationship between HPV infection and expression of p16 and EGFR in the tumor tissue and their clinical significance. Methods The infection of HPV6/ll, 16/18, 31/33 was detected by in situ hybridization (ISH), and expression of p16 and EGFR was assessed by immunohistochemistry in biopsy or surgical specimens of 43 cases of head and neck squamous cell carcinoma, and analyzed its impact on the prognosis. Spearman rank correlation method was used for analysis of the relationship. Overall survival rate of the patients was estimated by Kaplan-Meier analysis. Cox regression model was used for multivariate analysis. Results HPV6/ll, 16/18, 31/33 were detected in 25.6% ( 11/43 ) of this group of patients, among them, HPV16/18 accounted for 63.6% , HPV31/33 accounted for 27.3% , and HPV6/ll accounted for 0. EGFR was expressed in 69.8% and p16 was expressed in 53.5% of the patients. The difference was statistically significant between the HPV-positive and HPV-negative groups in ethnicity, smoking, alcohol consumption ( P = 0. 045, 0. 040, 0. 011, respectively). HPV infection was found to be positively correlated with p16 expression and inversely correlated with EGFR expression ( P = O. 029, P = 0. 009 ). The expression of p16 protein was negatively correlated with EGFR protein expression ( r = - 0. 447, P = 0. 003 ). The 3-year overall survival rate was 60.0% in the HPV-positive group and 59.7% in the negative group (P =0. 789); 72.2% in the p16positive patients and 43.9% in the pl6-negative patients ( P = 0. 012) ; 48.8% in the EGFR-positive patients and 81.8% in the EGFR-negative patients ( P = 0. 037). Conclusions The results of our study suggest that the HPV infection rate, HPV subtypes and clinicopathological features of HPV-positive SCCHN are in accordance with those reported in Western literatures. There may be differences between the HPV infections in Uygur and Han nationalities. HPV infection is positively correlated with p16 and negatively correlated with EGFR expressions. The prognosis of pl6-positive patients is significantly better than that of negative cases, and p16 is an independent prognostic factor for head and neck squamous cell carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2014年第1期23-28,共6页 Chinese Journal of Oncology
基金 科技部国际合作项目(2012DFA31560) 新疆维吾尔自治区国际合作项目(201141138)
关键词 肿瘤 鳞状细胞 头颈部肿瘤 人乳头瘤病毒 P16 受体 表皮生长因子 预后 Neoplasms, squamous cell Head and neck neoplasms Human papillomavirus p16 Receptor, epidermal growth factor Prognosis
  • 相关文献

参考文献22

  • 1张洁莉,孙昭,霍真,罗玉凤,马水清,王德田,曹金伶,杨缇,崔全才,白春梅.头颈部鳞癌人乳头状瘤病毒16/18感染状态与Ki-67、P53表达的关系[J].中国医学科学院学报,2010,32(4):429-432. 被引量:13
  • 2Gillison ML,Koch WM,Capone RB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2000,(9):709-720.
  • 3Argiris A,Karamouzis MV,Raben D. Head and neck cancer[J].{H}LANCET,2008,(9625):1695-1709.
  • 4Fakhry C,Westra WH,Li S. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2008,(4):261-269.
  • 5Ang KK,Harris J,Wheeler R. Human papillomavirus and survival of patients with oropharyngeal cancer[J].{H}New England Journal of Medicine,2010,(1):24-35.
  • 6Shi W,Kato H,Perez-Ordonez B. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma[J].{H}Journal of Clinical Oncology,2009,(36):6213-6221.
  • 7Wang XI,Thomas J,Zhang S. Changing trends in human papillomavirusassociated head and neck squamous cell carcinoma[J].{H}Annals of Diagnostic Pathology,2012,(1):7-12.
  • 8Hammarstedt L,Lindquist D,Dahlstrand H. Human papillomaviras as a risk factor for the increase in incidence of tonsillar cancer[J].{H}International Journal of Cancer,2006,(11):2620-2623.
  • 9Kreimer AR,Clifford GM,Boyle P. Human papillomavirus types in head and neck squamous cell carcinomas worldwide:a systematic review[J].{H}Cancer Epidemiology Biomarkers & Prevention,2005,(2):467-475.
  • 10Chemock RD,Zhang Q,El-Mofty SK. Human papillomavirusrelated squamous cell carcinoma of the oropharynx:a comparative study in whites and African Americans[J].{H}Archives of Otolaryngology Head and Neck Surgery,2011,(2):163-169.

二级参考文献63

  • 1Brennan JA,Boyle JO,Koch WM,et al.Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck.N Engl J Med,1995,332:712-717.
  • 2Michalides R,van Veelen N,Hart A,et al.Overexpression of cyclin DI correlates with recurrence in a group of forty-seven operable squamons cell carcinomas of the head and neck.Cancer Res,1995,55:975-978.
  • 3Klussmann JP,Mooren JJ,Lehnen M,et al.Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.Clin Cancer Res,2009,15:1779-1786.
  • 4Nichols AC,Faquin WC,Westra WH,et al.HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.Otolaryngol Head Neck Surg,2009,140:228-234.
  • 5Lindel K,Beer KT,Laissue J,et al.Human papillomavirus positive squamous cell carcinoma of the oropharynx:a radiosensitive subgroup of head and neck carcinoma.Cancer,2001,92:805-813.
  • 6Gupta AK,Lee JH,Wilke WW,et al.Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.Int J Radiat Oncol Biol Phys,2009,74:928-933.
  • 7Lassen P,Eriksen JG,Hamilton-Dutoit S,et al.Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.J Clin Onco1,2009,27:1992-1998.
  • 8Weinberger PM,Yu Z,Haffty BG,et al.Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis.J Clin Oncol,2006,24:736-747.
  • 9Fakhry C,Westra WH,Li S,et al.Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.J Natl Cancer Inst,2008,100:261-269.
  • 10Bosch FX,Lorincz A,Mu(n)oz N,et al.The causal relation between human papillomavirus and cervical cancer.J Clin Pathol,2002,55:244-265.

共引文献68

同被引文献115

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部